ORCL Research Update — April 20, 2026
Updated Thesis
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a strong legacy in database technology and a growing cloud business. The company benefits from a durable competitive moat supported by high insider ownership, experienced leadership, and a history of strategic acquisitions. Oracle's recent financials show robust revenue growth of 21.7% and earnings growth of 26.7% in the most recent quarter, driven by explosive cloud revenue growth of 44% year-over-year.
The investment grade as of this refresh is C — average business quality. High-tier business, C-tier valuation with 137% upside to $415.43 fair value
Key Metrics at a Glance
- Revenue growth: +21.7% year over year
- Net margin: 25.3%
- Forward P/E: 30.8x
- Fair value upside: +137.3% to our estimate of $415
Current price: $175.08
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Oracle Corporation remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full ORCL research →](/stocks/ORCL)